Abstract
Purpose
This study aimed to demonstrate the clinical course of Japanese patients with macular telangiectasia type 2 (MacTel-2).
Methods
This retrospective observational case series included 16 eyes of 8 Japanese patients (3 men and 5 women) with MacTel-2. The mean age and follow-up duration was 66.9 years and 42.8 months, respectively. Differences in best-corrected visual acuity (BCVA), funduscopic macular findings, central macular thickness (CMT), and the length of macular ellipsoid zone (EZ) loss were compared between the initial/baseline and final visits. Optical coherence tomographic changes in CMT by ≥ 20% and in EZ loss by ≥ 20% or ≥ 100 μm were defined as improved or worsened.
Results
Numerical changes in BCVA and EZ loss during follow-up were not statistically significant. However, the mean CMT at baseline, which was lower than that of healthy control eyes (P < 0.001), significantly increased during follow-up (P = 0.041). A certain proportion of eyes showed improvement in several parameters: funduscopic findings (both parafoveal retinal graying and foveal retinal pigment epithelium depigmentation) in 29% of eyes, CMT in 21% of eyes, and EZ loss in 43% of eyes.
Conclusions
The non-negligible proportion of eyes with improved parameters, marked especially by macular EZ loss, suggests that Japanese patients with MacTel-2 have milder clinical features than Caucasian patients reported in the literature.
Similar content being viewed by others
Data availability
All data generated or analyzed during this study are included in this published article.
References
Gass JD, Blodi BA (1993) Idiopathic juxtafoveolar retinal telangiectasis: update of classification and follow-up study. Ophthalmology 100:1536–1546
Yannuzzi LA, Bardal AM, Freund KB, Chen KJ, Eandi CM, Blodi B (2006) Idiopathic macular telangiectasia. Arch Ophthalmol 124:450–460
Charbel Issa P, Gillies MC, Chew EY, Bird AC, Heeren TFC, Peto T, Holz FG, Scholl HPN (2013) Macular telangiectasia type 2. Prog Retin Eye Res 34:49–77
Clemons TE, Gillies MC, Chew EY, Bird AC, Peto T, Figueroa, Harrington MW, MacTel Research Group (2010) Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel Project Report No. 2. Ophthalmic Epidemiol 17:66–73
Toygar O, Guess MG, Youssef DS, Miller DM (2016) Long-term outcomes of intravitreal bevacizumab therapy for subretinal neovascularization secondary to idiopathic macular telangiextasia type 2. Retina 36:2150–2157
Powner MB, Gillies MC, Tretiach M, Scott A, Guymer RH, Hageman GS, Fruttiger M (2010) Perifoveal Müller cell depletion in a case of macular telangiectasia type 2. Ophthalmology 117:2407–2416
Peto T, Heeren TFC, Clemons TE, Sallo FB, Leung I, Chew EY, Bird AC (2018) Correlation of clinical and structural progression with visual acuity loss in macular telangiectasia type 2: MacTel Project Report No. 6-The MacTel Research Group. Retina 38(Suppl 1):S8–S13
Maruko I, Iida T, Sekiryu T, Fujiwara T (2008) Early morphological changes and functional abnormalities in group 2A idiopathic juxtafoveolar retinal telangiectasis using spectral domain optical coherence tomography and microperimetry. Br J Ophthalmol 92:1488–1491
Heeren TFC, Kitka D, Florea D, Clemons TE, Chew EY, Bird AC, Pauleikhoff D, Charbel Issa P, Holz FG, Peto T (2018) Longitudinal correlation of ellipsoid zone loss and functional loss in macular telangiectasia type 2. Retina 38(Suppl 1):S20–S26
Wong WT, Forooghian F, Majumdar Z, Bonner RF, Cunningham D, Chew EY (2009) Fundus autofluorescence in type 2 idiopathic macular telangiectasia: correlation with optical coherence tomography and microperimetry. Am J Ophthalmol 148:573–583
Maruko I, Iida T, Sugano Y, Ojima A, Oyamada H, Sekiryu T (2012) Demographic features of idiopathic macular telangiectasia in Japanese patients. Jpn J Ophthalmol 56:152–158
Ooto S, Hangai M, Takayama K, Ueda-Arakawa N, Tsujikawa A, Yamashiro K, Oishi A, Hanebuchi M, Yoshimura N (2013) Comparison of cone pathologic changes in idiopathic macular telangiectasia types 1 and 2 using adaptive optics scanning laser ophthalmoscopy. Am J Ophthalmol 155:1045–1057.e4
Shinkai A, Saito W, Hashimoto Y, Ishida S (2019) Improvements in visual acuity and macular morphology following cessation of anti-estrogen drugs in a patient with anti-estrogen maculopathy resembling macular telangiectasia type 2: a pathogenic hypothesis. BMC Ophthalmol 19:267
Pauleikhoff D, Bonelli R, Dubis AM, Gunnemann F, Rothaus K, Charbel Issa P, Heeren TF, Peto T, Clemons TE, Chew EY, Bird AC, Sallo FB, MacTel Study Group (2019) Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2. Acta Ophthalmol 97:e998–e1005
Scerri TS, Quaglieri A, Cai C, Zernant J, Matsunami N, Baird L, Scheppke L, Bonelli R, Yannuzzi LA, Friedlander M, MacTel Project Consortium, Egan CA, Fruttiger M, Leppert M, Allikmets R, Bahlo M (2017) Genome-wide analyses identify common variants associated with macular telangiectasia type 2. Nat Genet 49:559–567
Gantner ML, Eade K, Wallace M, Fallon R, Trombley J, Bonelli R, Giles S, Harkins-Perry S, Heeren TFC, Sauer L, Ideguchi Y, Baldini M, Scheppke L, Dorrell MI, Kitano M, Hart BJ, Cai C, Nagasaki T, Badur MG, Okada M, Woods SM, Egan C, Gillies M, Guymer R, Eichler F, Bahlo M, Fruttiger M, Allikmets R, Bernstein PS, Metallo CM, Friedlander M (2019) Serine and lipid metabolism in macular disease and peripheral neuropathy. N Engl J Med 381:1422–1433
Othman A, Rütti MF, Ernst D, Saely CH, Rein P, Drexel H, Porretta-Serapiglia C, Lauria G, Bianchi R, von Eckardstein A, Hornemann T (2012) Plasma deoxysphingolipids: a novel class of biomarkers for the metabolic syndrome? Diabetologia 55:421–431
Clemons TE, Gillies MC, Chew EY, Bird AC, Peto T, Wang JJ, Mitchell P, Ramdas WD, Vingerling JR, Macular Telangiectasia Project Research Group (2013) Medical characteristics of patients with macular telangiectasia type 2 (MacTel type 2) MacTel project report no. 3. Ophthalmic Epidemiol 20:109–113
Weiter JJ, Delori FC, Wing GL, Fitch KA (1986) Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Invest Ophthalmol Vis Sci 27:145–152
Oshima Y, Ishibashi T, Tahara Y, Tahara Y, Kiyohara Y, Kubota T (2001) Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study. Br J Ophthalmol 85:1153–1157
Saito S, Saito W, Saito M, Hashimoto Y, Mori S, Noda K, Namba K, Ishida S (2015) Acute zonal occult outer retinopathy in Japanese patients: clinical features, visual function, and factors affecting visual function. PLoS One 10:e0125133
Ando R, Saito W, Kanda A, Kase S, Fujinami K, Sugahara M, Nakamura Y, Eguchi S, Mori S, Noda K, Shinoda K, Ishida S (2018) Clinical features of Japanese patients with anti-α-enolase antibody-positive autoimmune retinopathy: novel subtype of multiple drusen. Am J Ophthalmol 196:181–196
Charbel Issa P, Helb HM, Holz FG, MacTel Study Group (2008) Correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia. Am J Ophthalmol 145:169–175
Toto L, Di Antonio L, Mastropasqua R, Mattei PA, Carpineto P, Borrelli E, Rispoli M, Lumbroso B, Mastropasqua L (2016) Multimodal imaging of macular telangiectasia type 2: focus on vascular changes using optical coherence tomography angiography. Invest Ophthalmol Vis Sci 57:OCT268–OCT276
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The current study was approved by the ethics committee of Hokkaido University Hospital (#018-0207).
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Consent for publication
Written informed consent was obtained from the patient for publication of this case report and any accompanying images.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shinkai, A., Saito, W., Hashimoto, Y. et al. Morphological features of macular telangiectasia type 2 in Japanese patients. Graefes Arch Clin Exp Ophthalmol 259, 1179–1189 (2021). https://doi.org/10.1007/s00417-020-04989-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-020-04989-x